NL-OMON40371已完成不适用
Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cystic fibrosis: pharmacokinetics (PK) - TAPAS-PK study in patients with CF
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •* Age * 18 years;
- •* FEV1 predicted * 30%;
- •* Clinical diagnosis of CF and a positive sweat test or two CF-related mutations;
- •* Chronic PA colonization requiring;
- •* Ability to breathe through a mouthpiece and to use the inhaler;
- •* Ability to perform lung function tests;
- •* Written informed consent.
排除标准
- •* Severe acute exacerbation of pulmonary infection (needing intravenous treatment);
- •* Patients receiving intravenous tobramycin treatment;
- •* Patients who are pregnant, planning to become pregnant or breastfeeding;
- •* Known impaired kidney function (estimated creatinine clearance < 60 ml/min);
- •* Known aminoglycoside hypersensitivity;
- •* Therapy (e.g. furosemide) or disease which may complicate evaluation of the study protocol, as judged by the investigator;
- •* Participation in another drug-investigating clinical study at the start or within 1 month prior to the start;
- •* Inability to follow instructions of the investigator.
研究者
相似试验
进行中(未招募)
不适用
Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cystic fibrosis: pharmacokinetics (PK)Cystic fibrosisEUCTR2013-004488-30-NLHaga Hospital
招募中
4 期
Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cystic fibrosis100836241000401810024970Cystic fibrosismucoviscidosisNL-OMON41894Erasmus MC, Universitair Medisch Centrum Rotterdam6
招募中
不适用
TAPAS study in patients with CFCystic FibrosisTobramycinNL-OMON27235Erasmus Medical Center - Sophia Children's Hospital26
进行中(未招募)
不适用
Once daily deep inhalation of tobramycin with smart nebulizer more effective to treat small airways disease in cystic fibrosis?Cystic Fibrosis and chronic infection with Pseudomonas aeruginosaEUCTR2014-001401-41-NL26
进行中(未招募)
1 期
Targeting Antibiotics to Pseudomonas aeruginosa in Small airways study in patients with Cystic FibrosisCystic Fibrosis and chronic infection with Pseudomonas aeuroginosaMedDRA version: 22.1Level: LLTClassification code 10057582Term: Lung infection pseudomonalSystem Organ Class: 100000004862EUCTR2014-001401-41-ITERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM26
